Drug Type Small molecule drug, ASO |
Synonyms ALG-ASO |
Target |
Action stimulants, inhibitors |
Mechanism CFTR stimulants(Cystic fibrosis transmembrane conductance regulator stimulants), Viral RNA inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cystic Fibrosis | Preclinical | United States | 01 Mar 2026 | |
| Hepatitis B | Preclinical | United States | - |





